Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals

被引:420
作者
Fried, LF
Shlipak, MG
Crump, C
Bleyer, AJ
Gottdiener, JS
Kronmal, RA
Kuller, LH
Newman, AB
机构
[1] VA Pittsburgh Healthcare Syst, Renal Sect, Pittsburgh, PA 15240 USA
[2] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA
[3] Vet Affairs Med Ctr, Med Serv, San Francisco, CA 94121 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA
[7] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[8] Wake Forest Univ, Sch Med, Nephrol Sect, Winston Salem, NC 27109 USA
[9] St Francis Hosp, Div Cardiol, Roslyn, NY USA
[10] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA
[11] Univ Pittsburgh, Sch Med, Div Geriatr Med, Pittsburgh, PA 15260 USA
关键词
D O I
10.1016/S0735-1097(03)00163-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study was designed to evaluate the relationship between elevated creatinine levels and cardiovascular events. BACKGROUND End-stage renal disease is associated with high cardiovascular morbidity and mortality. The association of mild to moderate renal insufficiency with cardiovascular outcomes remains unclear. METHODS We analyzed data from the Cardiovascular Health Study, a prospective population-based study of subjects, aged >65 years, who had a serum creatinine measured at baseline (n = 5,808) and were followed for a median of 7.3 years. Proportional hazards models were used to examine the association of creatinine to all-cause mortality and incident cardiovascular mortality and morbidity. Renal insufficiency was defined as a creatinine level greater than or equal to1.5 mg/dl in men or greater than or equal to1.3 mg/dl in women. RESULTS An elevated creatinine level was present in 648 (11.2%) participants. Subjects with elevated creatinine had higher overall (76.7 vs. 29.5/1,000 years, p < 0.001) and cardiovascular (35.8 vs. 13.0/1,000 years, p < 0.001) mortality than those with normal creatinine levels. They were more likely to develop cardiovascular disease (54.0 vs. 31.8/1,000 years, p < 0.001), stroke (21.1 vs. 11.9/1,000 years, p < 0.001), congestive heart failure (38.7 vs. 17/1,000 years, p < 0.001), and symptomatic peripheral vascular disease (10.6 vs. 3.5/1,000 years, p < 0.001). After adjusting for cardiovascular risk factors and subclinical disease measures, elevated creatinine remained a significant predictor of all-cause and cardiovascular mortality, total cardiovascular disease (CVD), claudication, and congestive heart failure (CHF). A linear increase in risk was observed with increasing creatinine. CONCLUSIONS Elevated creatinine levels are common in older adults and are associated with increased risk of mortality, CVD, and CHF. The increased risk is apparent early in renal disease. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:1364 / 1372
页数:9
相关论文
共 46 条
[31]   Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin [J].
Levin, A ;
Thompson, CR ;
Ethier, J ;
Carlisle, EJF ;
Tobe, S ;
Mendelssohn, D ;
Burgess, E ;
Jindal, K ;
Barrett, B ;
Singer, J ;
Djurdjev, O .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (01) :125-134
[32]  
Macy EM, 1997, CLIN CHEM, V43, P52
[33]   Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial [J].
Mann, JFE ;
Gerstein, HC ;
Pogue, J ;
Bosch, J ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :629-636
[34]   The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure [J].
McTiernan C.F. ;
Feldman A.M. .
Current Cardiology Reports, 2000, 2 (3) :189-197
[35]  
Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745
[36]  
Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606
[37]  
Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8
[38]   Serum Interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy [J].
Roig, E ;
Orús, J ;
Paré, C ;
Azqueta, M ;
Filella, X ;
Perez-Villa, F ;
Heras, M ;
Sanz, G .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (05) :688-+
[39]  
Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218
[40]   Cardiovascular disease and chronic renal disease: A new paradigm [J].
Sarnak, MJ ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :S117-S131